News

Acambis has delivered 182.5 million doses of ACAM2000 to the US Government for its emergency-use Strategic National Stockpile and has orders from several other governments around the world

Looking forward for the full year 2009, the company anticipates that its reported revenues will be between a 1% decline and 1% growth over 2008. Excluding a 4%

Participation in the Pilot 2 program is limited to no more than one fast track product for each review division within the Center for Drug Evaluation and Research

In February 2002, VaxGen and a group of South Korean investors formed Celltrion, a South Korean joint venture, to establish a large-scale biopharmaceutical manufacturing business in South Korea.

Like all two million North American Indians, the Burt Lake Band has an extremely high rate of adult-onset diabetes. At a recent Tribal Council meeting, GenoMed was approved

In the letter, the FDA requests additional supportive efficacy data on the product candidate and additional information related to manufacturing aspects of the product. H3 Pharma intends to

Acute myocardial infarction (AMI), or heart attack, is the number one disease-related cause of death in the developed world with approximately 2.1 million new cases per year in

The company stated the plan realigns its business strategy, focusing on its core competencies of formulation development of controlled-release pharmaceuticals and distribution, and divesting or seeking other strategic

AstraZeneca has taken this decision after consultation with the EMEA in view of the Iressa survival evaluation in lung cancer (ISEL) survival results, which will not meet the